Influence of Basal Insulin and Glucagon Secretion on Potassium and Sodium Metabolism: STUDIES WITH SOMATOSTATIN IN NORMAL DOGS AND IN NORMAL AND DIABETIC HUMAN BEINGS
AUTOR(ES)
Defronzo, Ralph A.
RESUMO
To examine the role of basal insulin and glucagon secretion in potassium and sodium homeostasis, somatostatin, a potent inhibitor of insulin and glucagon secretion, was infused for 5 h into healthy human subjects, maturity-onset diabetes, juvenile-onset diabetics, and normal dogs. Infusion of somatostatin resulted in an increase in serum potassium (0.5-0.6 meq/liter) in normal subjects and maturity-onset diabetics, but not in juvenile-onset diabetics despite equivalent reductions in plasma glucagon in all three groups. A similar rise in serum potassium was observed in normal conscious dogs given somatostatin and was reversed by insulin replacement. Urinary excretion of potassium was unaffected by somatostatin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=372558Documentos Relacionados
- Somatostatin-Induced Changes in Insulin and Glucagon Secretion in Normal and Diabetic Dogs
- THE EFFECT OF GLUCAGON ON CARBOHYDRATE METABOLISM IN NORMAL HUMAN BEINGS 1
- STUDIES OF SODIUM AND POTASSIUM METABOLISM. THE EFFECT OF POTASSIUM ON THE SODIUM AND WATER BALANCES IN NORMAL SUBJECTS AND PATIENTS WITH BRIGHT'S DISEASE
- Vagal regulation of insulin, glucagon, and somatostatin secretion in vitro in the rat.
- Influence of 2,3-diphosphoglycerate metabolism on sodium-potassium permeability in human red blood cells: studies with bisulfite and other redox agents